Pass on majority or the entire cost to consumers, which will increase prices
Reassess their portfolio, and remove unviable products from that
Manufacturing in the US, but that is unlikely to have any cost advantage for generic drugs.
US President Don…
Trump 25% Tariffs: Pharma stocks that may buck the trend and options that lie before them
